The global neurodegenerative disease market is likely to register a CAGR of over 3.2% with an incremental growth of USD 7.1 billion during the forecast period 2022-2028.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global neurodegenerative disease market. It traces the market's historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors' approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the neurodegenerative disease industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the indication, drug, and region. The global market for neurodegenerative disease can be segmented by indication: Parkinson's disease, Alzheimer's disease, multiple sclerosis, Huntington's disease, others. Among these, the multiple sclerosis segment was accounted for the highest revenue generator in 2021. Neurodegenerative disease market is further segmented by drug: N-methyl-D-aspartate receptor antagonist, cholinesterase inhibitor, dopamine agonist, immunomodulatory drug, others. The immunomodulatory drug segment is estimated to account for the largest share of the global neurodegenerative disease market. Based on region, the neurodegenerative disease market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest share of the global neurodegenerative disease market in 2021 and is anticipated to hold its share during the forecast period.
Market Segmentation
By indication: Parkinson's disease, Alzheimer's disease, multiple sclerosis, Huntington's disease, others
By drug: N-methyl-D-aspartate receptor antagonist, cholinesterase inhibitor, dopamine agonist, immunomodulatory drug, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The market research report covers the analysis of key stake holders of the global neurodegenerative disease market. Some of the leading players profiled in the report include Abbvie Inc., Amneal Pharmaceuticals Inc., Biogen Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Novartis AG, Pfizer Inc., Roche Holding AG, Teva Pharmaceuticals Ltd., UCB S.A., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global neurodegenerative disease market.
- To classify and forecast the global neurodegenerative disease market based on indication, drug, region.
- To identify drivers and challenges for the global neurodegenerative disease market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global neurodegenerative disease market.
- To identify and analyze the profile of leading players operating in the global neurodegenerative disease market.
Why Choose This Report
- Gain a reliable outlook of the global neurodegenerative disease market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY INDICATION
· Parkinson's disease
· Alzheimer's disease
· Multiple sclerosis
· Huntington's disease
· Others
PART 6. MARKET BREAKDOWN BY DRUG
· N-methyl-D-aspartate receptor antagonist
· Cholinesterase inhibitor
· Dopamine agonist
· Immunomodulatory drug
· Others
PART 7. MARKET BREAKDOWN BY REGION
· North America
· Europe
· Asia-Pacific
· MEA (Middle East and Africa)
· Latin America
PART 8. KEY COMPANIES
· Abbvie Inc.
· Amneal Pharmaceuticals Inc.
· Biogen Inc.
· Boehringer Ingelheim International GmbH
· Merck & Co. Inc.
· Novartis AG
· Pfizer Inc.
· Roche Holding AG
· Teva Pharmaceuticals Ltd.
· UCB S.A.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Executive Summary
Azoth Analytics has released a research report titled "Global Infectious Disease In vitro Diagnostics Market (2024 Edition)" which provides a complete analysis of the Global Infectious Disease In vitro Diagnostics industry in terms of market segmentation By Technology ...
Executive Summary
Azoth Analytics has released a research report titled "Global Irritable Bowel Disease Market (2024 Edition)" which provides a complete analysis of the Global Irritable Bowel Disease industry in terms of market segmentation By Drug Class (Corticosteroids, JAK inhibitors...
The Chronic Disease Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...
The Chronic Disease Data Management Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
Overview of the Global Rare Disease Pharmaceutical Service Market:
The report discusses everything a marketer requires before investing in the global Rare Disease Pharmaceutical Service Market during the forecast pe...
Executive Summary
Azoth Analytics has released a research report titled "Cystic Fibrosis Lung Disease Market (2024 Edition)" which provides a complete analysis of the global Cystic Fibrosis Lung Disease industry in terms of market segmentation by Drug Type (CFTR Modulators, Bronchodilat...
Overview of the Global Alzheimer's Disease Population Screening Software Market:
The report discusses everything a marketer requires before investing in the global Alzheimer's Disease Population Screening Software M...
Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...
Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...
North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...